A green and efficient integrated extraction process for gentian root extract
By using a pre-aqueous DES system and multi-stage membrane separation and purification technology, the compatibility problem between DES extract and membrane separation system was solved, achieving efficient, green, and safe preparation of gentian root extract, suitable for high-end skincare products.
Patent Information
- Application Number
- CN202611445879.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-17
- Publication Date
- 2026-11-17
AI Technical Summary
In existing technologies, DES extraction of gentian root is difficult to effectively integrate with membrane separation and purification systems, resulting in high viscosity and numerous impurities in the extract, which affects product quality and safety. Furthermore, DES is difficult to recycle, heat-sensitive components are easily degraded, and the purity of active ingredients is low, making it difficult to meet the high-quality requirements of skincare products.
A pre-aqueous DES system is adopted, combined with pretreatment steps of dilution, cooling and settling, and pH adjustment to reduce the viscosity of the extract and remove macromolecular impurities. Through three-stage membrane separation purification and low-temperature concentration, the DES extract is seamlessly connected to the membrane separation system, and the DES is recycled.
This technology achieves high compatibility between DES extract and membrane separation system, significantly improves the retention rate and purity of gentiopicrin, reduces production costs, meets the high-quality requirements of skincare products, and conforms to the concept of green chemistry.
Smart Images

Figure CN123106785A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of plant extraction and separation technology, specifically to a green and efficient integrated extraction process for gentian root extract. Background Technology
[0002] Gentian (including but not limited to the dried roots and rhizomes of *Gentiana manshurica* Kitag., *Gentiana scabra* Bunge, *Gentiana triflora* Pall., or *Gentianarigescens* Franch.) is a perennial herbaceous plant belonging to the genus *Gentiana* in the family Gentianaceae. Its roots are used medicinally, possessing the effects of clearing heat and drying dampness, and purging liver and gallbladder fire. The gentian root raw material described in this invention is commercially available or conventionally cultivated and harvested, with a clearly defined source. Gentian root contains various active ingredients such as gentiopicrin, swertiamarin, and gentianine, among which gentiopicrin is its main active ingredient and indicative component. Modern pharmacological studies have shown that gentiopicrin has significant anti-inflammatory, antioxidant, and soothing antipruritic effects. Based on these effects, gentian root extract has received considerable attention in the skincare industry in recent years and is widely used in the development of functional cosmetics for anti-allergy, antipruritic, soothing repair, and sensitive skin care.
[0003] Currently, the extraction processes for gentian root extract mainly include organic solvent extraction and water extraction. Organic solvents such as methanol, ethyl acetate, and ethanol have high extraction efficiency, but the large amount of reagents used and the use of volatile toxic reagents pose significant safety and health risks. While water extraction is safe, it has low extraction efficiency, high impurity dissolution, and is difficult to purify subsequently. More importantly, for skincare raw materials, organic solvent residues pose safety hazards and do not meet the increasingly stringent safety and environmental protection requirements for cosmetic raw materials; while the large number of impurities in water extracts, such as pigments, proteins, and tannins, not only affect the appearance and stability of the product but may also cause skin irritation or allergies, limiting its application in high-end sensitive skin skincare products. Therefore, finding an extraction method that is both efficient and safe is of significant practical importance.
[0004] In recent years, deep eutectic solvents (DES) have been considered a novel green solvent due to their simple preparation, low cost, environmental friendliness, low volatility, strong dissolving power, and designable structure, and have been used for the extraction of active ingredients from traditional Chinese medicine. For gentian extraction, several patents and literature have reported the application of DES.
[0005] Chinese patent application CN115212151A (publication date October 21, 2022) discloses a method for extracting gentian extract. This method uses a eutectic solvent as the extraction solvent to perform ultrasonic-assisted extraction on the whole *Gentiana yunnanensis* plant, followed by centrifugation to remove impurities and concentration to obtain the gentian extract. The eutectic solvent is composed of betaine and one or two of 1,3-butanediol, urea, glycerol, 1,3-propanediol, or lactic acid. The advantages of this method are the use of ultrasonic-assisted extraction technology and a eutectic solvent, which improves extraction efficiency, shortens extraction time, and reduces the use of organic solvents. However, this process only involves centrifugation and simple concentration after DES extraction to obtain the product, without effectively connecting the extract to subsequent purification units. A large number of impurities such as pigments, proteins, and polysaccharides in the DES extract are not removed. If this extract is used directly in skincare products, the impurities may affect the product's color, odor, and stability, and there is a potential risk of allergic reactions, making it difficult to meet the high purity and low impurity requirements of skincare products.
[0006] Chinese patent application CN119775328A (publication date April 8, 2025) also discloses a method for preparing gentian extract using a deep eutectic solvent. This method uses DES (diethylstilbestrol) composed of betaine and 1,3-propanediol or glycerol as the extraction solvent, intermittently sonicating gentian powder, and then centrifuging to obtain gentiopicrin extract. This method is green, safe, and environmentally friendly, with a simple preparation process and high extraction efficiency. Similar to CN115212151A, this process also stops at centrifugation, without further purification of the DES extract, and does not address the connection between the DES extract and subsequent purification processes. The resulting product is still a crude extract containing a large number of impurities, making it difficult to use directly as a high-quality skincare ingredient.
[0007] Furthermore, Chinese patent application CN116870094A (publication date October 13, 2023) relates to a method for preparing a heat-clearing and detoxifying oral liquid, which contains thirteen medicinal herbs including gentian. This process employs two different extraction and purification routes: on the one hand, the aqueous extract is filtered using a modified ultrafiltration membrane; on the other hand, the filter residue after water extraction is subjected to a secondary extraction using a eutectic solvent to obtain a glycoside extract. That is, the membrane separation process in this patent targets the aqueous extract, not the DES extract. DES is only used to treat the solid residue after water extraction; the two are in different process flows, and there is no technical solution for DES extract to enter the membrane separation system. Moreover, the target product of this patent is an oral liquid preparation, whose purification requirements and impurity control indicators are completely different from those of skincare product raw materials. Skincare product raw materials have much higher requirements for color, odor, and allergenic impurities than oral liquids, and some components allowed in oral liquids may cause adverse skin reactions in skincare products.
[0008] In summary, although existing DES extraction technology for gentian root has achieved green extraction, it still has the following shortcomings: First, existing purification methods after DES extraction are limited and cannot meet the quality requirements of skincare product raw materials. CN115212151A and CN119775328A obtain products simply through centrifugation and concentration after DES extraction, failing to effectively remove large molecular impurities such as pigments, proteins, polysaccharides, and tannins from the extract, resulting in limited product purity and quality. Directly using such crude extracts in skincare products not only affects the color, odor, and stability of the formula, but the impurities may also cause skin irritation or allergic reactions, limiting their application in high-end skincare products.
[0009] Secondly, there is a compatibility gap between DES and membrane separation systems. Membrane separation technology, due to its advantages such as room-temperature operation, molecular-level separation, and no phase change, is considered an ideal method for purifying heat-sensitive plant active ingredients, especially suitable for preparing high-purity plant extracts for skincare products. Although CN116870094A uses ultrafiltration membranes for the purification of gentian-related extracts, it processes aqueous extracts, not DES extracts. The high viscosity and high osmotic pressure characteristics of DES extracts, if directly introduced into a membrane separation system, will lead to a sharp decrease in membrane flux, accelerated membrane fouling, and a significant shortening of membrane lifespan. Currently, there is no effective solution to the integration problem between DES extracts and membrane separation systems, which severely restricts the application of DES extraction technology in the preparation of high-quality gentian root extracts for skincare products.
[0010] Third, DES is difficult to recycle. Existing DES extraction technologies, such as CN115212151A and CN119775328A, typically discard DES after a single use, failing to achieve recycling. This increases production costs and wastewater discharge, hindering the promotion of green environmental protection and sustainable development concepts in the production of skincare raw materials.
[0011] Fourth, gentiopicroside is easily degraded and inactivated during traditional purification processes. Gentianoprothiolane has an easily degraded, active hemiacetal structure that is unstable under high temperatures. The thermal concentration step in existing processes may lead to the loss of heat-sensitive components, directly affecting the efficacy of the extract in skincare products.
[0012] Fifth, although gentian extract extracted using existing technologies has certain anti-inflammatory and antipruritic effects, it lacks effective purification processes, resulting in high impurity content and low purity of active ingredients. This limits its addition amount and compatibility in skincare product formulations, making it difficult to achieve precise quantification of active ingredients and maximize efficacy.
[0013] Therefore, how to achieve effective compatibility and integration of DES extract and membrane separation system while maintaining the high efficiency and environmental friendliness of DES extraction, and form a complete, industrial-scale, green and efficient extraction process suitable for preparing high-quality gentian root extract for skin care products, has become a technical problem that urgently needs to be solved in this field. Summary of the Invention
[0014] This invention addresses the technical shortcomings of existing technologies where DES extraction of gentian root is difficult to effectively integrate with membrane separation and purification systems. It provides a green and efficient integrated extraction process for gentian root extract. This process integrates DES extraction, pretreatment and conditioning, multi-stage membrane separation and purification, and low-temperature concentration, achieving seamless integration of DES extraction and membrane separation. It offers advantages such as high extraction efficiency, good retention of active ingredients, environmental friendliness, and suitability for industrial production.
[0015] To achieve the above-mentioned objectives, the present invention provides the following technical solution: A green and efficient integrated extraction process for gentian root extract includes the following steps: Step 1, DES extraction: Gentian root raw material was subjected to ultrasonic-assisted extraction using a eutectic solvent as the extraction solvent, and crude DES extract was obtained after solid-liquid separation.
[0016] Preferably, the eutectic solvent is composed of choline chloride and lactic acid in a molar ratio of 1:2 to 1:5, and 15% to 30% of deionized water is added during the synthesis of the eutectic solvent.
[0017] Preferably, the temperature of the ultrasound-assisted extraction is 30-50℃, the time is 20-60 minutes, and the ultrasound power is 200-500W.
[0018] This invention employs a choline chloride-lactic acid (DES) system as the extraction solvent, exhibiting excellent selective extraction capability for gentiopicrin. Specifically, this invention incorporates 15%-30% deionized water (i.e., a "pre-hydrated" design) during the DES synthesis stage, rather than adding water during extraction. This seemingly simple adjustment in operational sequence actually produces unexpected technical benefits: the pre-hydrated DES, while forming a hydrogen bond network, possesses a lower initial viscosity, resulting in better fluidity of the extract from the outset, laying the foundation for subsequent integration with the membrane separation system. Furthermore, the low-temperature ultrasonic extraction conditions of 30-50°C, far lower than the 70°C or higher temperatures required for traditional organic solvent extraction, effectively prevent thermal degradation of gentiopicrin during the extraction stage.
[0019] Step 2, Pretreatment: The crude DES extract is diluted and cooled to obtain a pretreated solution.
[0020] Preferably, the dilution involves adding 0.5-2 times the volume of a diluent to the crude DES extract, wherein the diluent is deionized water or a 5%-10% aqueous ethanol solution.
[0021] Preferably, the diluent is pre-cooled to 4-10°C before use.
[0022] Preferably, the cooling process involves allowing the diluted liquid to stand at 4-10°C for 1-3 hours.
[0023] Preferably, the method further includes adjusting the pH of the diluted solution to 4.0-6.0.
[0024] This step is the core of this invention in resolving the "compatibility gap" between DES extract and membrane separation systems. Its beneficial effects are multiple and synergistic, specifically manifested in: First, by employing a dual strategy of "pre-aqueous DES extraction + post-extraction gradient dilution," the viscosity of the DES extract (measured as 186.5 cP in Example 1) was reduced from an initial several hundred cP to a range acceptable for membrane separation (<50 cP), achieving "viscosity matching" between the DES extract and the membrane separation system. It is well known to those skilled in the art that the high viscosity of DES makes it considered incompatible with membrane separation systems. This is the fundamental reason why existing technologies (such as CN115212151A and CN119775328A) stop at centrifugal separation and fail to perform membrane separation of the DES extract. This invention overcomes this technical prejudice through a pretreatment unit.
[0025] Secondly, this invention employs a "slow addition + pre-cooling diluent" method for dilution, producing a synergistic effect that cannot be achieved by a single dilution operation. It is well known to those skilled in the art that the mixing of DES with water is a strongly exothermic process; if diluted directly at room temperature, the sudden rise in local temperature will lead to the thermal degradation of gentiopicrin. This invention, by using a diluent pre-cooled to 4-10°C, precisely neutralizes the exothermic effect of dilution, keeping the solution consistently at a low temperature and avoiding localized thermal damage to the active ingredients. This simultaneous achievement of "viscosity reduction" and "protection" is something that those skilled in the art could not foresee when facing dilution operations.
[0026] Furthermore, this invention involves a cooling and settling process at 4-10°C after dilution. At this temperature, the solubility of large molecular impurities such as tannins, colloids, proteins, and polysaccharides in the DES-water mixture decreases dramatically, causing them to precipitate prematurely. This means that some contaminants are actively removed before entering the membrane separation system, rather than relying entirely on the membrane for retention. This operation simultaneously achieves the triple functions of "viscosity reduction and membrane permeation promotion," "cooling to protect components," and "impurity precipitation and membrane protection."
[0027] Finally, the pH is adjusted to 4.0-6.0 to match the feed solution with the membrane separation operating conditions, thus avoiding fluctuations in membrane material performance and loss of effective components caused by adjusting the pH after the feed solution enters the membrane system.
[0028] The above four sub-steps (dilution, precooling, cooling and settling, pH adjustment) are not simply an addition of operations, but a systematic and synergistic design to address specific compatibility issues between the DES extract and the membrane separation system. The overall effect is far greater than the simple sum of the effects of each sub-step implemented individually.
[0029] Step 3: Membrane separation and purification: The pretreated solution is sequentially passed through microfiltration, ultrafiltration, and nanofiltration membranes for cross-flow filtration and staged membrane separation. The nanofiltration retentate is collected. Each membrane separation unit adopts cross-flow filtration mode, with the cross-flow velocity controlled at 2-4 m / s. The permeate is returned to the feed tank for recycling and concentration.
[0030] Preferably, the microfiltration membrane has a pore size of 0.1-0.45 μm, the ultrafiltration membrane has a molecular weight cutoff of 5-10 kDa, and the nanofiltration membrane has a molecular weight cutoff of 150-300 Da.
[0031] This step, through a three-stage membrane separation design, achieves a synergistic effect of "step-by-step removal of impurities + enrichment of active ingredients + in-situ recovery of DES," specifically manifested in: First stage, microfiltration (0.1-0.45μm): Removes suspended particles, bacteria, and some large colloidal molecules, protecting the subsequent ultrafiltration membrane from particulate contamination.
[0032] The second stage, ultrafiltration (5-10 kDa): allows small-molecule active ingredients such as gentiopicroside (molecular weight approximately 356 Da) to pass through, while retaining large-molecule impurities such as proteins, polysaccharides, and tannins. Because the pretreatment step has already precipitated a large amount of large-molecule colloidal impurities, the fouling load on the ultrafiltration membrane is significantly reduced, resulting in a substantial increase in membrane flux and membrane lifespan. This synergistic effect of "pretreatment burden reduction" and "ultrafiltration retention" enables the ultrafiltration membrane to operate efficiently with a relatively low risk of fouling.
[0033] The third stage, nanofiltration (150-300 Da): Those skilled in the art generally believe that nanofiltration is only used for concentration or desalination, and given the high osmotic pressure of DES, it is usually expected that nanofiltration membranes cannot effectively treat DES-containing solutions, or that DES will severely contaminate the nanofiltration membrane. However, this invention unexpectedly discovered that within the 150-300 Da molecular weight cutoff window of the nanofiltration membrane, gentiopicroside (356 Da) is effectively retained, while some DES components (choline chloride with a molecular weight of approximately 139.6 Da and lactic acid with a molecular weight of approximately 90 Da) permeate. This means that nanofiltration achieves in-situ removal and preliminary recovery of DES while concentrating the effective components. Both "purification" and "solvent removal" are completed simultaneously within the same membrane separation unit—a "double-edged sword" effect that cannot be achieved with a single membrane separation operation.
[0034] The synergistic relationship between the three membrane separation stages is particularly crucial: microfiltration removes suspended solids, reducing the contamination load on ultrafiltration; ultrafiltration retains large molecular impurities, further reducing the burden on nanofiltration; and nanofiltration achieves maximum separation precision in a clean environment. The output of each stage is precisely the optimal input for the next, and this "tiered protection" significantly improves the overall operating efficiency and membrane lifespan of the membrane separation system compared to single-stage or simple two-stage membrane separation schemes. More importantly, because the pretreatment step removes a large amount of impurities, the purity of the feed entering the nanofiltration system is far higher than that of the untreated DES extract. This allows the nanofiltration membrane to operate stably with a lower risk of contamination, creating a deep synergy between pretreatment and membrane separation.
[0035] Step 4: Low-temperature concentration: The nanofiltration retentate is concentrated at a temperature below 60°C to obtain a concentrated gentian root extract.
[0036] Preferably, the low-temperature concentration is vacuum concentration, with a temperature of 40-50℃ and a vacuum degree of -0.08 to -0.095 MPa.
[0037] Low-temperature vacuum concentration at 40-50℃ is significantly lower than the temperature of traditional thermal concentration (70-80℃), effectively protecting the activity of heat-sensitive components such as gentiopicrin.
[0038] Most importantly, this invention constructs a "full-process low-temperature chain" from extraction to concentration: pre-hydrated DES low-temperature extraction (30-50℃) → pretreatment cooling and settling (4-10℃) → room temperature membrane separation (15-30℃) → low-temperature vacuum concentration (40-50℃). In this chain, the material does not undergo significant temperature increases after leaving the high-temperature extraction environment, effectively avoiding the shortcoming of "extraction is preserved, concentration decomposes" in traditional processes. Each individual low-temperature step can reduce thermal degradation losses in a single operation, while the full-process low-temperature chain constructed by this invention prevents the cumulative effect of "thermal shock" caused by high-temperature switching of gentiopicrin throughout the entire processing cycle. This "no thermal peak throughout" series protection makes the total retention rate significantly better than the simple linear superposition expectation of the effects of each individual low-temperature step (in Experimental Example 6, the expected retention rate of group B and group C after simply adding the high-temperature losses of each individual step was about 69%, while the actual retention rate of group A at the full-process low temperature was 96.5%, significantly higher than the linear expectation), demonstrating the synergistic thermal protection effect between multiple unit operations.
[0039] Step 5, DES Recovery: The nanofiltration permeate from Step 3 is subjected to vacuum distillation at 60-80℃ and a vacuum degree of -0.085 to -0.095 MPa to remove water to 1 / 5-1 / 3 of its original volume, yielding a concentrated recovered DES solution. After confirming the DES composition ratio by HPLC analysis, appropriate amounts of choline chloride and lactic acid are added to bring the initial molar ratio to 1:2-1:5, allowing it to be recycled for use in Step 1. The recovery rate of DES components in a single recovery process is not less than 92%.
[0040] Utilizing the high DES content and water content in nanofiltration permeate, DES can be recovered and recycled through simple vacuum distillation. This not only reduces production costs and wastewater discharge but also creates a closed loop of "extraction-purification-recovery-reuse," aligning with the principles of green chemistry and a circular economy. In existing technologies (such as CN115212151A and CN119775328A), DES is typically discarded after a single use; this invention achieves the resource-based recycling of DES.
[0041] Compared with the prior art, the present invention has the following beneficial effects: This invention, through a pretreatment combination scheme of "pre-hydrated DES + gradient dilution + pre-cooling dilution + cooling and settling + pH adjustment", successfully reduced the viscosity of DES extract to an acceptable range for membrane separation, filling the technical gap of lacking an effective means of connecting DES extract and membrane separation system.
[0042] The four sub-steps of the pretreatment unit in this invention are not simply superimposed, but systematically coordinated to achieve the synergistic function of "viscosity reduction + component protection + impurity removal + membrane protection"; nanofiltration simultaneously completes the concentration of effective components and in-situ removal of DES within the molecular weight window of 150-300 Da, achieving an unexpected "two birds with one stone" effect; microfiltration, ultrafiltration, and nanofiltration form a "step-by-step burden reduction" protection chain, which significantly extends the service life of the membrane.
[0043] The continuous low-temperature chain from extraction to concentration in this invention results in a much lower thermal history accumulation of gentiopicrin compared to traditional processes, effectively avoiding the shortcomings of "extraction preservation and concentration decomposition".
[0044] The nanofiltration permeate of this invention can be recycled by vacuum distillation to recover DES, realizing a closed-loop operation of "extraction-purification-recovery-reuse", reducing production costs and waste discharge.
[0045] The various technical units of this invention work together in a deep synergy, and the overall effect far exceeds the simple sum of individual methods. The gentian root extract obtained has a stable content of gentiopicroside of over 3000 ppm, and impurities are effectively removed. It can be used directly as a high-quality skin care product raw material and has good industrialization prospects. Attached Figure Description
[0046] Figure 1 This is a schematic diagram of the green and efficient integrated extraction process for gentian root extract of the present invention; Figure 2 This is a comparison chart of the viscosity of the DES extract before and after pretreatment in Example 1; Figure 3 This is a graph showing the change in membrane flux over time during the membrane separation process in Example 1. Figure 4 This is a graph showing the change in membrane flux over operating time during direct membrane separation without pretreatment in Comparative Example 1. Figure 5 A comparison chart showing the gentiopicroside content of gentian root extracts obtained from different extraction processes. Detailed Implementation
[0047] The present invention will be further illustrated below through specific embodiments. It should be understood that these embodiments are for illustrative purposes only and are not intended to limit the scope of the invention. All technologies implemented based on the above description of the present invention fall within the scope of the present invention. Experimental methods in the following embodiments that do not specify specific conditions are generally performed under conventional conditions or as recommended by the manufacturer. Unless otherwise stated, percentages and parts are by weight.
[0048] Detection method: The content of gentiopicrin was determined by high performance liquid chromatography (HPLC). The chromatographic conditions were as follows: a C18 column (4.6 mm × 250 mm, 5 μm); a mobile phase of acetonitrile-0.1% phosphoric acid aqueous solution with gradient elution; a detection wavelength of 254 nm; a flow rate of 1.0 mL / min; and a column temperature of 30 °C. Gentianopeptide standards were purchased from the National Institutes for Food and Drug Control (NIFDC).
[0049] The viscosity of the DES extract was measured using a rotational viscometer (Brookfield DV-II+Pro) at 20°C, with a shear rate of 100 s⁻¹. -1 .
[0050] Membrane flux was measured by gravimetric method, and the calculation formula is: J = V / (A×t), where J is the membrane flux (L·m). -2 ·h -1 V is the volume of permeate (L), and A is the effective area of the membrane (m²). 2 ), where t is the running time (h).
[0051] The retention rate of gentiopicrin is calculated using the following formula: Retention rate (%) = (Gentiopicrin content in the final product / Gentianopeptide content in the extract) × 100%.
[0052] Protein content was determined using the Coomassie brilliant blue method, polysaccharide content was determined using the phenol-sulfuric acid method, and color was determined by spectrophotometry using absorbance at 420 nm.
[0053] Example 1 Step 1: Preparation of DES Choline chloride and lactic acid were mixed in a molar ratio of 1:3 and heated at 70°C with stirring for 1.5 hours until a homogeneous and transparent liquid was formed. Heating was then stopped, and when the temperature dropped to 50-60°C, 20% (v / v) deionized water was slowly added dropwise with continuous stirring (the dropping rate was controlled at 5-10 mL / min). After the addition was complete, stirring was continued for 30 minutes to obtain an aqueous DES extraction solvent.
[0054] Step 2, DES extraction: 100g of dried gentian root was pulverized and passed through a 60-mesh sieve. The gentian root powder was added to the DES extraction solvent prepared in step one at a material-to-liquid ratio of 1:20 (g / mL). Ultrasonic-assisted extraction was performed at 40℃ with a power of 300W and a frequency of 30kHz for 40 minutes. After extraction, the mixture was centrifuged at 6000rpm for 15 minutes, and the supernatant was collected to obtain the crude DES extract. The measured viscosity of this crude DES extract at 25℃ was 186.5 cP (using a Brookfield DV-II+Pro rotational viscometer, shear rate 100s). -1 (Constant temperature at 20℃).
[0055] HPLC-ELSD analysis of the nanofiltration permeate obtained in step four showed that the permeate rate of choline chloride was 82.3%, the permeate rate of lactic acid was 89.7%, and the retention rate of gentiopicroside (molecular weight approximately 356 Da) was 98.2%. These data indicate that, at a molecular weight cutoff of 200 Da, small molecule components of DES preferentially permeate through the nanofiltration membrane, while the target active ingredient is efficiently retained.
[0056] Step 3, Preprocessing: The crude DES extract obtained in step two was slowly added to one volume of pre-cooled deionized water at 4°C under stirring. The pH was adjusted to 5.0 with citric acid, and the solution was allowed to stand at 4°C for 2 hours. The solution was then filtered through a 0.45μm microfiltration membrane to obtain the pretreated solution.
[0057] Step 4: Membrane separation and purification: The pretreated solution obtained in step three is passed through the following steps sequentially: First-stage microfiltration: using a ceramic microfiltration membrane with a pore size of 0.22μm, operating pressure 0.2MPa; Second-stage ultrafiltration: A regenerated cellulose ultrafiltration membrane with a molecular weight cutoff of 8 kDa is used, with an operating pressure of 0.5 MPa; The third stage of nanofiltration uses a nanofiltration membrane with a molecular weight cutoff of 200 Da and an operating pressure of 1.5 MPa.
[0058] Collect the permeate and retentate from each stage separately, and collect the nanofiltration retentate.
[0059] Step 5: Low-temperature concentration: The nanofiltration retentate obtained in step four was concentrated to 1 / 8 of its original volume at 45°C and a vacuum of -0.09 MPa to obtain a concentrated gentian root extract.
[0060] Step Six: DES Recycling The nanofiltration permeate from step four was subjected to vacuum distillation to recover the DES components. After adding appropriate amounts of choline chloride and lactic acid, it was recycled for use in step one.
[0061] Experiment Example 1: Comparison Experiment of Pre-hydrated DES and Water Addition During Extraction To verify the superiority of the "pre-hydrated" design of this invention, a control group was set up: DES was synthesized in the same molar ratio (1:3) of choline chloride-lactic acid system under anhydrous conditions, and an equal amount of deionized water (20% v / v) was temporarily added during extraction. The remaining extraction conditions were exactly the same as in Example 1.
[0062] The results showed that the initial viscosity of the crude DES extract in the control group (temporarily replenished with water) was 245.8 cP (25℃), significantly higher than the 186.5 cP of the pre-hydrated group of this invention. Furthermore, the temporary water replenishment process was highly exothermic, with the local solution temperature instantly rising to 58℃. HPLC analysis showed that the gentiopicrin extraction rate in the control group (temporarily replenished with water) was 35.0 mg / g, while the extraction rate in Example 1 (pre-hydrated) was 36.5 mg / g, a decrease of approximately 4.1%. Statistical analysis (t-test, n=3) showed a statistically significant difference between the two groups (P<0.05). This indicates that pre-hydrated synthesis allows for more uniform embedding into the DES hydrogen bond network, more effectively reducing system viscosity and avoiding localized overheating. This comparative result fully demonstrates the superiority of pre-hydrated operation in viscosity control and component protection.
[0063] Example 2 Step 1: Preparation of DES Choline chloride and lactic acid were mixed in a molar ratio of 1:4 and heated at 80°C with stirring for 1 hour to form a homogeneous and transparent liquid. Heating was then stopped, and when the temperature dropped to 50-60°C, 25% (v / v) deionized water was slowly added dropwise with continuous stirring (the dropping rate was controlled at 5-10 mL / min). After the addition was complete, stirring was continued for 30 minutes to obtain an aqueous DES extraction solvent.
[0064] Step 2, DES extraction: Take 100g of dried gentian root and pulverize it through a 40-mesh sieve. Add the gentian root powder to the DES extraction solvent prepared in step one at a material-to-liquid ratio of 1:15 (g / mL). Perform ultrasonic-assisted extraction at 35℃, with an ultrasonic power of 400W and a frequency of 25kHz for 30 minutes. After extraction, centrifuge at 5000rpm for 20 minutes and collect the supernatant to obtain the crude DES extract.
[0065] Step 3, Preprocessing: The crude DES extract obtained in step two was slowly added to 1.5 times its volume of 8% ethanol aqueous solution pre-cooled to 4°C under stirring. The pH was adjusted to 5.5 with sodium bicarbonate. The solution was allowed to stand at 4°C for 1.5 hours and then filtered through a 0.45μm microfiltration membrane to obtain the pretreated solution.
[0066] Step 4: Membrane separation and purification: The pretreated solution obtained in step three is passed through the following steps sequentially: First-stage microfiltration: using a ceramic microfiltration membrane with a pore size of 0.1μm, operating pressure 0.25MPa; Second-stage ultrafiltration: A regenerated cellulose ultrafiltration membrane with a molecular weight cutoff of 5 kDa is used, and the operating pressure is 0.6 MPa; The third stage of nanofiltration uses a nanofiltration membrane with a molecular weight cutoff of 150 Da and an operating pressure of 1.8 MPa.
[0067] Collect the nanofiltration retentate.
[0068] Step 5: Low-temperature concentration: The nanofiltration retentate obtained in step four was concentrated to 1 / 10 of its original volume at 40°C and a vacuum of -0.095 MPa to obtain a concentrated gentian root extract.
[0069] Example 3 Step 1: Preparation of DES Choline chloride and lactic acid were mixed in a molar ratio of 1:2 and heated at 60°C with stirring for 2 hours to form a homogeneous and transparent liquid. Heating was then stopped, and when the temperature dropped to 50-60°C, 30% (v / v) deionized water was slowly added dropwise with continuous stirring (the dropping rate was controlled at 5-10 mL / min). After the addition was complete, stirring was continued for 30 minutes to obtain an aqueous DES extraction solvent.
[0070] Step 2, DES extraction: Take 100g of dried gentian root and pulverize it through an 80-mesh sieve. Add the gentian root powder to the DES extraction solvent prepared in step one at a material-to-liquid ratio of 1:25 (g / mL). Perform ultrasonic-assisted extraction at 50℃, with an ultrasonic power of 200W and a frequency of 40kHz for 60 minutes. After extraction, centrifuge at 8000rpm for 10 minutes and collect the supernatant to obtain the crude DES extract.
[0071] Step 3, Preprocessing: The crude DES extract obtained in step 2 was slowly added to 2 times the volume of deionized water pre-cooled to 10°C under stirring. The pH was adjusted to 4.5 with citric acid, and the solution was allowed to stand at 10°C for 1 hour. The solution was then filtered through a 0.45μm microfiltration membrane to obtain the pretreated solution.
[0072] Step 4: Membrane separation and purification: The pretreated solution obtained in step three is passed through the following steps sequentially: First-stage microfiltration: using a ceramic microfiltration membrane with a pore size of 0.45μm, operating pressure 0.15MPa; Second-stage ultrafiltration: A regenerated cellulose ultrafiltration membrane with a molecular weight cutoff of 10 kDa is used, with an operating pressure of 0.4 MPa; The third stage of nanofiltration uses a nanofiltration membrane with a molecular weight cutoff of 300 Da and an operating pressure of 1.2 MPa.
[0073] Collect the nanofiltration retentate.
[0074] Step 5: Low-temperature concentration: The nanofiltration retentate obtained in step four was concentrated to 1 / 6 of its original volume at 50°C and a vacuum of -0.08 MPa to obtain a concentrated gentian root extract.
[0075] Comparative Example 1 (Direct membrane separation without pretreatment) The same DES extraction conditions as in Example 1 were used (choline chloride and lactic acid molar ratio 1:3, water content 20%, ultrasonic extraction at 40°C for 40 minutes, material-liquid ratio 1:20), but the pretreatment step was omitted and the crude DES extract was directly fed into the membrane separation system (using the same three-stage membrane separation parameters as in Example 1).
[0076] The results showed that when the crude DES extract was directly introduced into the microfiltration membrane, the membrane flux dropped to 30% of its initial value after 10 minutes of operation, and a gel layer appeared on the surface of the microfiltration membrane, making continuous operation impossible. Due to the lack of pretreatment, large molecular impurities in the feed solution directly entered the membrane modules of the ultrafiltration and nanofiltration membranes, accelerating the membrane fouling rate; the membrane modules required cleaning and regeneration after 30 minutes of operation. Comparative Example 1 failed to obtain a stable gentian root extract product.
[0077] Comparative Example 2 (without cooling and settling treatment) The same DES extraction conditions and dilution ratio as in Example 1 were used, but the cooling and settling step was omitted (i.e., after dilution, the product was not settling at 4°C for 2 hours, but was directly introduced into the membrane separation system after 0.45 μm microfiltration).
[0078] The results showed that macromolecular impurities in the feed solution that had not undergone cooling and settling treatment failed to fully precipitate at low temperatures, and the fouling rate of the microfiltration membrane was faster than in Example 1. After 60 minutes of operation, the membrane flux of the microfiltration membrane decreased to 55% of its initial value (compared to 82% of the initial value in Example 1 after the same operating time). The cleaning cycle of the ultrafiltration membrane was shortened from 96 hours in Example 1 to 48 hours.
[0079] Comparative Example 3 (using non-pre-cooled diluent) The same DES extraction conditions, dilution ratio, and cooling and standing conditions as in Example 1 were used, but the diluent (deionized water) was not pre-cooled before use (i.e., it was diluted with deionized water at room temperature of 25°C).
[0080] The results showed that during the dilution process at room temperature, the heat of dilution generated by mixing DES with water led to a local temperature increase in the solution. Monitoring with a temperature recorder showed that the peak temperature of the solution reached 52℃ during the dilution process. HPLC analysis showed that the gentiopicroside content in the final product obtained in this comparative example was 2840 ppm, lower than the 3127 ppm in Example 1, with a gentiopicroside retention rate of 90.8%, while the gentiopicroside retention rate in Example 1 was 96.5%. This indicates that without the use of a pre-cooling diluent, the local temperature rise during the dilution process led to the thermal degradation of some gentiopicroside.
[0081] Comparative Example 4 (using single-stage nanofiltration concentration, without microfiltration and ultrafiltration) The same DES extraction and pretreatment conditions as in Example 1 were used, but the microfiltration and ultrafiltration steps were omitted, and the pretreatment solution was directly introduced into the nanofiltration membrane (molecular weight cutoff 200 Da, operating pressure 1.5 MPa).
[0082] The results showed that in the feed solution without microfiltration and ultrafiltration pretreatment, suspended particles and macromolecular impurities directly entered the nanofiltration membrane, causing the nanofiltration membrane flux to drop to 50% of its initial value after 40 minutes of operation, and the membrane fouling rate was higher than in Example 1 (where the nanofiltration membrane flux was 78% of its initial value after 120 minutes of operation). The final product had a higher residual pigment content, and the product color was darker than in Example 1.
[0083] Comparative Example 5 (using a non-inventory DES composition, betaine-lactic acid system) Betaine was used instead of choline chloride as the hydrogen bond acceptor, and lactate was mixed with it at a molar ratio of 1:3 to form DES (without pre-added water). The other conditions were the same as in Example 1.
[0084] The results showed that the gentiopicroside extraction rate of the betaine-lactic acid DES extract was 28.5 mg / g, lower than the 36.5 mg / g in Example 1. Under the same pretreatment and membrane separation conditions, the membrane flux of the betaine-lactic acid DES extract was 15% lower than that of Example 1.
[0085] Comparative Example 6 (using the method of existing technology CN115212151A) Following the method described in Example 1 of CN115212151A: Whole *Gentiana yunnanensis* plants were taken, washed, dried at 50°C for 12 hours, and pulverized through a 60-mesh sieve. Betaine and 1,3-butanediol were mixed at a molar ratio of 1:4 and heated at 80°C and 400 rpm for 1 hour to form DES. *Gentiana yunnanensis* powder was mixed with DES at a ratio of 1:20, sonicated at 300W and 40°C for 15 minutes, centrifuged at 2000 rpm for 10 minutes, and the supernatant was concentrated to obtain the gentian extract.
[0086] The results showed that the gentian extract obtained by this method contained 2850 ppm of gentiopicroside, 3.2 times the protein residue of Example 1, 2.8 times the polysaccharide residue of Example 1, and the product was dark brownish-yellow in color.
[0087] Process verification experiment Experimental Example 2: Effect of Pretreatment on the Viscosity of DES Extract The viscosity of the crude DES extract obtained in step two of Example 1 and the pretreated solution obtained in step three was measured at 20°C.
[0088] The results showed that the viscosity of the untreated DES crude extract was 185 cP (20℃). After pretreatment (adding one volume of deionized water pre-cooled to 4℃ and letting it stand at 4℃ for 2 hours), the viscosity of the pretreated solution was 18 cP (20℃), a decrease to 9.7% of the untreated solution. The reduction in viscosity allowed the pretreated solution to enter the membrane separation system, while the untreated DES crude extract, due to its excessively high viscosity, could not be directly subjected to membrane separation.
[0089] Experimental Example 3: Effect of Pretreatment on Membrane Flux Under the same membrane separation conditions (microfiltration membrane pore size 0.22 μm, operating pressure 0.2 MPa), the pretreatment solution of Example 1 and the crude DES extract of Comparative Example 1 were subjected to microfiltration membrane filtration, and the membrane flux was recorded over time.
[0090] The results showed that the initial membrane flux of the pretreatment solution in Example 1 was 185 L·m⁻¹. -2 ·h -1 After 120 minutes of operation, the membrane flux was 152 L·m³. -2 ·h -1 The initial flux of the crude DES extract in Comparative Example 1 was 82 L·m⁻¹, which was 82% of the initial value. -2 ·h -1 After running for 10 minutes, it dropped to 19 L·m -2 ·h -1 The initial value was 30%, and after 30 minutes of operation, the membrane flux decreased to 8 L·m³. -2 ·h -1 It can no longer function effectively.
[0091] The above results indicate that the pretreatment step plays a role in maintaining membrane flux and ensuring the continuous and stable operation of the membrane separation system. Untreated DES extract is too viscous to be effectively compatible with the membrane separation system.
[0092] Experiment Example 4: The effect of membrane separation at different stages on impurity removal The composition of the liquid obtained in each step of Example 1 was analyzed, and the results are shown in Table 1.
[0093] Table 1. Composition changes during membrane separation at each stage in Example 1 The results showed that ultrafiltration removed 92.7% of proteins and 91.4% of polysaccharides. Nanofiltration further removed residual small molecule impurities and effectively retained gentiopicrin. The final product contained 3127 ppm of gentiopicrin.
[0094] Experimental Example 5: Effect of different concentration methods on the retention rate of gentiopicrin The nanofiltration retentate obtained in step four of Example 1 (gentiopicroside content 3120 ppm) was concentrated using the following three methods: Method A: Low-temperature vacuum concentration at 45℃ and a vacuum degree of -0.09MPa to 1 / 8 of the original volume; Method B: Concentrate to 1 / 8 of the original volume at 75℃ and normal pressure; Method C: Freeze-dry at -50℃ to the same solid content.
[0095] The content of gentiopicroside in the products obtained by each method was determined, and the retention rate was calculated. The results are shown in Table 2.
[0096] Table 2. Effects of different concentration methods on the retention rate of gentiopicrin The results showed that the retention rate of gentiopicrin by low-temperature vacuum concentration at 45℃ (96.5%) was higher than that by concentration at 75℃ under normal pressure (82.7%). Gentianopeptide is thermally unstable and easily decomposes under high-temperature conditions. Although the retention rate of freeze-drying (94.4%) was also relatively high, its equipment investment and operating costs were higher than those of low-temperature vacuum concentration.
[0097] Experiment Example 6: Verification of the cumulative protective effect of cryogenic operation throughout the entire process To verify the cumulative protective effect of the low-temperature operation throughout the entire process of this invention on gentiopicroside, the following three sets of comparative experiments were set up: Group A: Extraction at 40℃ → Pretreatment at 4℃ → Membrane separation at 25℃ → Concentration at 45℃, with a maximum temperature of 45℃ throughout the process; Group B: Extraction at 70℃ → Pretreatment at 4℃ → Membrane separation at 25℃ → Concentration at 45℃; Group C: Extraction at 40℃ → Pretreatment at 4℃ → Membrane separation at 25℃ → Concentration at 75℃.
[0098] Other conditions for the three groups of experiments were the same as in Example 1. The content of gentiopicroside in the final product of each group was determined, and the total retention rate was calculated. The results are shown in Table 3.
[0099] Table 3 Comparison of total retention rate of gentiopicrin under different temperature conditions The results showed that the total retention rate of group A (96.5%) was higher than that of group B (86.7%) and group C (82.7%). The extraction loss of group B was 260 ppm, and the concentration loss of group C was 560 ppm. The expected loss of the two groups when simply added together was 820 ppm, while the actual loss of group A was only 113 ppm, which was lower than the expected value.
[0100] Experiment Example 7: Verification of DES Recycling and Reuse Effects Three DES recycling experiments were conducted according to the method in Example 1. Fresh DES was used in the first experiment, and recycled DES was used in the second and third experiments (with appropriate amounts of choline chloride and lactic acid added to the initial molar ratio). The results are shown in Table 4.
[0101] Table 4. DES Recycling Effect The results showed that the extraction rates of the recovered DES in the second and third uses were 98.1% and 96.4% of those of the fresh DES, respectively, with no significant decrease in extraction rate, and the appearance of the extract was consistent with that of the fresh DES extract.
[0102] Experiment Example 8: Product Stability Study The gentian root extract concentrate obtained in Example 1 was sealed and stored at room temperature and protected from light. Samples were taken at 0, 1, 3 and 6 months to determine the gentiopicrin content. The results are shown in Table 5.
[0103] Table 5 Results of Product Stability Study The results showed that, under normal temperature, light-proof, and sealed storage conditions, the gentiopicrin content in the gentian root extract concentrate obtained in Example 1 remained above 97% of the initial content within 6 months, indicating good product stability.
[0104] Product testing results Gentian root extract concentrate was prepared according to the method in Example 1, and the results were as follows: The appearance is a pale yellow to brownish-yellow clear liquid; the refractive index (20℃) is 1.3960; the pH value is 4.30; the gentiopicroside content is 3127 ppm; the total bacterial count is <10 CFU / mL; the yeast and mold count is <10 CFU / mL; thermostable Escherichia coli was not detected; lead is <5 mg / kg; mercury is <1 mg / kg; arsenic is <2 mg / kg; and cadmium is <1 mg / kg.
[0105] Working principle description The core of this invention lies in the effective integration of DES extraction, pretreatment conditioning, multi-stage membrane separation and purification, and low-temperature concentration units, thereby achieving efficient connection between DES extraction and membrane separation. Its working principle can be explained from the following two aspects: (I) Mechanism of the pretreatment unit in solving DES-membrane compatibility issues The high viscosity of DES is a major obstacle limiting its compatibility with membrane separation systems. This invention addresses this problem through the following approach: First, 15%-30% deionized water is introduced during the DES synthesis stage (“pre-water” design) to give DES a low initial viscosity at the beginning of its formation.
[0106] Secondly, after extraction, a gradient dilution is performed by adding 0.5-2 times the volume of pre-cooling diluent to further reduce the viscosity of the DES extract. The pre-cooling diluent also absorbs the heat released during dilution, preventing localized thermal damage to the active ingredients.
[0107] Furthermore, by cooling and allowing the mixture to stand at 4-10℃, the solubility of large molecular impurities decreases at low temperatures, allowing some impurities to precipitate out in advance, thus reducing the contamination load of subsequent membrane separation.
[0108] Finally, by adjusting the pH to 4.0-6.0, the feed solution is matched with the membrane separation operating conditions to avoid changes in membrane material performance and loss of effective components due to pH fluctuations after the feed solution enters the membrane system.
[0109] (II) Molecular weight gradient separation mechanism of three-stage membrane separation This invention employs a three-stage membrane separation design of "microfiltration → ultrafiltration → nanofiltration," with the separation precision of each membrane stage increasing progressively. Microfiltration membranes (0.1-0.45μm) remove suspended particles, bacteria, and some large colloidal molecules, thus protecting the subsequent ultrafiltration membranes.
[0110] Ultrafiltration membranes (with a molecular weight cutoff of 5-10 kDa) allow small-molecule active ingredients such as gentiopicroside (molecular weight of about 356 Da) to pass through, while retaining large-molecule impurities such as proteins, polysaccharides, and tannins.
[0111] Nanofiltration membranes (with a molecular weight cutoff of 150-300 Da) retain gentiopicroside (356 Da) while allowing some DES components and water molecules to permeate. The underlying mechanism is as follows: Under the specific pretreatment solution environment of this invention (pH 4.0-6.0, sufficient water content), choline chloride exists primarily as a dissociated cation (molecular weight 139.6 Da), and lactic acid exists primarily as an anion or molecular (molecular weight 90 Da), both with extremely small hydration radii. Simultaneously, the nanofiltration membrane surface is typically negatively charged, exhibiting weak electrostatic repulsion towards monovalent small molecules based on the Donnan effect. Therefore, choline chloride and lactic acid can efficiently permeate through the nanofiltration membrane via a dual mechanism of "size sieving + reduced charge repulsion," while larger, uncharged or slightly charged gentiopicroside glycosides are physically retained, achieving precise in-situ simultaneous "concentration-DES removal" separation. This results in the enrichment of effective components and the initial separation of DES components.
[0112] The three membrane stages form a synergistic protective relationship of "tiered load reduction": the impurities removed by each stage membrane become the main source of pollution for the next stage membrane, and the output of the previous stage provides cleaner feed for the next stage, thereby extending the operating cycle and service life of the entire membrane separation system.
[0113] (III) System collaboration among various technical units The inventiveness of this invention lies not only in the individual technologies themselves, but also in the systematic synergy between these technologies. This is specifically reflected in the following three aspects: The first level: the synergistic "feedforward-response" approach of pretreatment and membrane separation. The pre-aqueous DES design ensures the extract has a low initial viscosity at the source (Example 1); gradient dilution after extraction further reduces the viscosity to an acceptable range for membrane separation (Example 2); cooling and settling allow large molecular impurities to precipitate prematurely, actively removing some contaminants (Comparative Example 2). This triple operation forms a progressive pretreatment chain of "source viscosity reduction—process dilution—early impurity precipitation," and its combined effect is far superior to any single operation: dilution alone only reduces viscosity (membrane flux still decreases rapidly), cooling alone only induces impurities (high viscosity still hinders membrane separation), while the combined operation maintains 82% of the initial membrane flux within 120 minutes (Example 3). This simultaneous achievement of "viscosity reduction + impurity precipitation" is impossible with a single operation.
[0114] The second level: the synergistic "step-by-step load reduction" of three-stage membrane separation. Microfiltration removes suspended particulate matter, providing clean feed for ultrafiltration; ultrafiltration retains large molecular impurities (protein removal rate 92.7%, polysaccharide removal rate 91.4%), providing ultra-clean feed for nanofiltration (Experimental Example 4); nanofiltration achieves high-precision separation in a low-pollution environment (gentiopicrin removal rate 98.2%). The impurities removed by each stage of the membrane are precisely the main sources of pollution for the next stage, forming a synergistic chain of step-by-step protection and load reduction. Comparative Example 4 shows that, omitting microfiltration and ultrafiltration, the nanofiltration membrane flux drops to 50% of its initial value within 40 minutes, while when the three membranes are run in series, the nanofiltration membrane still maintains 78% of its initial value after 120 minutes.
[0115] The third level: Synergistic "elimination of accumulated thermal history" through low-temperature operation throughout the entire process. Extraction (30-50℃) → Pretreatment (4-10℃) → Membrane separation (15-30℃) → Concentration (40-50℃) – the material never experiences a significant temperature increase throughout the entire processing cycle. Experimental Example 6 demonstrates that the expected retention rate of a simple linear summation of single-step high-temperature losses is approximately 69%, while the actual retention rate at low temperatures throughout the entire process reaches 96.5%, exceeding the expected value by nearly 30 percentage points. This indicates a synergistic thermal protection effect between the low-temperature steps; that is, the protection of heat-sensitive components in the preceding step preserves more "active reserves" for the subsequent step, making the total loss far lower than the simple sum of the losses from each step.
[0116] In summary, the various technical units of this invention have a functional mutual support and interaction relationship, and the overall technical effect is far greater than the simple superposition of individual means.
[0117] Feasibility analysis for industrial applications The equipment involved in each unit operation of this invention is all conventional equipment in the plant extraction industry, including ultrasonic extraction tanks, centrifuges, membrane separation equipment (microfiltration, ultrafiltration, nanofiltration), vacuum concentration tanks, and vacuum distillation devices. These devices have all been industrialized and applied.
[0118] Based on the process parameters of Example 1, the production capacity was estimated as follows: Each batch processes 100 kg of gentian root raw material (based on dried raw material), using approximately 2000 L of DES extraction solvent. After pretreatment, membrane separation, and low-temperature concentration, approximately 100 L of gentian root extract concentrate (gentiopicroside content approximately 3127 ppm) can be obtained. Assuming 5 batches are operated per week, the annual production capacity could reach approximately 26,000 L of concentrate (based on a 50-week cycle).
[0119] The operating costs of a membrane separation system mainly include the periodic replacement and cleaning costs of the membrane modules. Based on the membrane flux data in Example 1, the flux of the microfiltration membrane reaches 82% of its initial value after 120 minutes of operation. The cleaning cycle for the ultrafiltration membrane is 96 hours, and the cleaning cycle for the nanofiltration membrane is 120 hours. The replacement cycle for microfiltration and ultrafiltration membranes is approximately 6-12 months, and the replacement cycle for nanofiltration membranes is approximately 12-18 months.
[0120] The recycling of DES reduces the procurement costs of extraction solvents and the costs of waste liquid treatment. According to the results of Experiment 7, DES can be recycled at least 3 times while maintaining extraction efficiency.
[0121] Product Application Verification The gentian root extract concentrate obtained in Example 1 was used as a raw material and added to the basic skin care lotion formula at a mass fraction of 1% (the basic formula is a conventional water-in-oil lotion, without other anti-inflammatory and soothing active ingredients) for human skin patch test and lactic acid sting test.
[0122] Skin patch test: Thirty healthy subjects (aged 25-50 years) were selected. An emulsion containing 1% gentian root extract and a blank base were placed in separate patch chambers and applied to the backs of the subjects. Skin reactions were observed at 0.5 hours, 24 hours, and 48 hours after patch removal. Results showed that in the 30 subjects, no irritation reactions such as erythema, edema, or papules occurred in the emulsion group containing gentian root extract; all skin reaction ratings were grade 0 (negative).
[0123] Lactic acid stinging test: Fifteen subjects with sensitive skin, as determined by a 10% lactic acid stinging test, were selected. A lotion containing 1% gentian root extract was applied to one side of the face, while a blank base was applied to the other side. The lotion was used twice daily, morning and evening, for 14 consecutive days. Lactic acid stinging tests were conducted before use and on days 7 and 14 after use (10% lactic acid was applied to the nasolabial fold area, and the intensity of stinging sensation was assessed using a scoring system of 0-3 points). The results are shown in Table 6.
[0124] Table 6. Lactic acid stinging test scores The results showed that the lactic acid stinging score of the emulsion containing gentian root extract was lower than that of the blank matrix side on both days 7 and 14. Data are expressed as mean ± standard deviation (x ± s), and statistical analysis was performed using a paired-samples t-test. On day 14 after use, the score of the extract-containing side (0.9 ± 0.2) was significantly different from that of the blank matrix side (1.9 ± 0.3) (P < 0.01), demonstrating that the gentian root extract of this invention has a significant effect in soothing skin sensitivity and reducing stinging sensation.
[0125] The above description is merely a preferred embodiment of the present invention and is not intended to limit the invention. Various modifications and variations can be made to the present invention by those skilled in the art. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present invention should be included within the scope of protection of the present invention.
Claims
1. A green and efficient integrated extraction process for gentian root extract, characterized in that, Includes the following steps: (1) DES extraction: Gentian root raw material was extracted with ultrasonic assistance using a eutectic solvent and the crude DES extract was obtained after solid-liquid separation. (2) Pretreatment: The crude DES extract is diluted and cooled to obtain a pretreated solution; (3) Membrane separation and purification: The pretreated solution is sequentially passed through a microfiltration membrane, an ultrafiltration membrane and a nanofiltration membrane for cross-flow filtration and fractional membrane separation, and the nanofiltration retentate is collected; (4) Low temperature concentration: The nanofiltration retentate is concentrated at a temperature below 60°C to obtain a concentrated gentian root extract.
2. The green and efficient integrated extraction process for gentian root extract according to claim 1, characterized in that, The eutectic solvent is composed of choline chloride and lactic acid in a molar ratio of 1:2 to 1:5, and 15% to 30% of deionized water is added during the synthesis of the eutectic solvent.
3. The green and efficient integrated extraction process for gentian root extract according to claim 1, characterized in that, The temperature for ultrasound-assisted extraction in step (1) is 30-50℃, the time is 20-60 minutes, and the ultrasound power is 200-500W.
4. The green and efficient integrated extraction process for gentian root extract according to claim 1, characterized in that, The dilution in step (2) involves adding 0.5-2 times the volume of diluent to the crude DES extract. The diluent is deionized water or a 5%-10% aqueous ethanol solution.
5. The green and efficient integrated extraction process for gentian root extract according to claim 4, characterized in that, The diluent is pre-cooled to 4-10°C before use.
6. The green and efficient integrated extraction process for gentian root extract according to claim 1, characterized in that, The cooling process described in step (2) involves letting the diluted liquid stand at 4-10°C for 1-3 hours.
7. The green and efficient integrated extraction process for gentian root extract according to claim 1, characterized in that, Step (2) also includes adjusting the pH of the diluted solution to 4.0-6.
0.
8. The green and efficient integrated extraction process for gentian root extract according to claim 1, characterized in that, The microfiltration membrane in step (3) has a pore size of 0.1-0.45 μm, the ultrafiltration membrane has a molecular weight cutoff of 5-10 kDa, the nanofiltration membrane has a molecular weight cutoff of 150-300 Da, and the cross-flow velocity of the cross-flow filtration is 2-4 m / s.
9. The green and efficient integrated extraction process for gentian root extract according to claim 1, characterized in that, The low-temperature concentration mentioned in step (4) is vacuum concentration, with a temperature of 40-50℃ and a vacuum degree of -0.08 to -0.095MPa.
10. The green and efficient integrated extraction process for gentian root extract according to claim 1 or 8, characterized in that, It also includes a DES recovery step: the nanofiltration permeate from step (3) is subjected to vacuum distillation to recover the DES components and recycled for step (1).
Citation Information
Patent Citations
Extraction method of radix gentianae extract, radix gentianae extract and application of radix gentianae extract
CN115212151A
Preparation method of oral liquid capable of clearing away heat and toxic materials
CN116870094A
A method for preparing gentian extract using deep eutectic solvent and its application
CN119775328A
